Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
The Laryngoscope|July 3, 2021
Defining High-Quality Integrated Head and Neck Cancer Care Through a Composite Outcome Measure: Textbook OutcomeMaurits F J van der Heide, Dominique V C de Jel, Fieke Hoeijmakers, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 28, 2024
FGD-PET/CT three months after (chemo)radiotherapy for head and neck squamous cell carcinoma spares considerable number of patients from a salvage neck dissectionArash Navran, Mutamba T Kayembe, Zeno A R Gouw, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 13, 2017
Quality of life of patients with locally advanced head and neck cancer treated with induction chemotherapy followed by cisplatin-containing chemoradiotherapy in the Dutch CONDOR study: a randomized controlled trialChantal M L Driessen, Johannes M M Groenewoud, Jan Paul de Boer, et al.
JAMA Otolaryngology-- Head & Neck Surgery|August 21, 2015
Prediction of Hearing Loss Due to Cisplatin ChemoradiotherapyEleonoor A R Theunissen, Charlotte L Zuur, Katarzyna Józwiak, et al.
Head & Neck|March 3, 2015
Late follow-up of the randomized radiation and concomitant high-dose intra-arterial or intravenous cisplatin (RADPLAT) trial for advanced head and neck cancerJolien Heukelom, Marta Lopez-Yurda, Alfons J M Balm, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|April 16, 2015
Treatments and costs for recurrent and/or metastatic squamous cell carcinoma of the head and neck in the NetherlandsNaomi van der Linden, Jan Buter, Chris P Pescott, et al.
Head & Neck|August 6, 2011
Five-year quality of life results of the randomized clinical phase III (RADPLAT) trial, comparing concomitant intra-arterial versus intravenous chemoradiotherapy in locally advanced head and neck cancerAnnemieke H Ackerstaff, Coen R N Rasch, Alfons J M Balm, et al.
Head & Neck|December 15, 2018
HLA class II expression on tumor cells and low numbers of tumor-associated macrophages predict clinical outcome in oropharyngeal cancerBianca Cioni, Ekaterina S Jordanova, Erik Hooijberg, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 30, 2019
Immuno-radiotherapy with cetuximab and avelumab for advanced stage head and neck squamous cell carcinoma: Results from a phase-I trialJoris B W Elbers, Abrahim Al-Mamgani, Margot E T Tesseslaar, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 15, 2022
Retrospective analysis of PSMA PET/CT thyroid incidental uptake in adults: incidence, diagnosis, and treatment/outcome in a tertiary cancer referral center and University Medical CenterMarceline W Piek, Lisa H de Vries, Maarten L Donswijk, et al.
Pageof 8